Companies Dominating the Neurostimulator Device Landscape
-
Boston Scientific Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Medtronic PLC
- Abbott Laboratories
- Nevro Corp.
- Liva Nova PLC
- Axonics Modulation Technologies Inc.
- Neuropace Inc.
- EndoStimInc.
- NDI Medical
- Cochlear Limited
- Neuronetics Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2024, the industry size of neurostimulator device is assessed at USD 12.92 Billion.
The neurostimulator device market size was valued at USD 11.44 Billion in 2023 and is expected to reach USD 65.76 Billion by the end of 2036, expanding at around 14.4% CAGR during the forecast period i.e., between 2024-2036. Increasing elderly population and the rising prevalence of neurological disorders are the major factors driving the market growth.
North America is likely to dominate majority industry share by 2036, propelled by growing rate of neurological illnesses in the region.
Medtronic PLC, Abbott Laboratories, Nevro Corp., Liva Nova PLC, Axonics Modulation Technologies Inc., Neuropace Inc., EndoStimInc., NDI Medical, Cochlear Limited, Neuronetics Inc.
